A qualitative assessment of the adverse effects associated with COVID-19 vaccines : a study from Jordan
© 2023. Dr. Zaheer-Ud-Din Babar and Auckland UniServices Ltd..
OBJECTIVES: The current study aimed to qualitatively explore the side effects reported by participants who received the COVID-19 vaccine among the Jordanian population.
METHODS: Between April 18th and May 12th, 2022, an in-depth interview was conducted with a purposive sample of vaccinated individuals to assess the side effects of the COVID-19 vaccine in this study. Thematic analysis was used to identify themes and sub-themes within the current qualitative data.
RESULTS: A total of 20 participants were interviewed. They had a mean age of 41.3 (SD = 14.3) years. Half of the participants were females (n = 10, 50.0%). The study revealed six main themes: first, most of the respondents believed that COVID-19 vaccines were safe. Second, the vaccines are not equivalent in their safety. The third there showed that participants follow preventive measures to decrease the possibility of experiencing side effects. The fourth theme showed that reporting of side effects by the participants is dependent on the experienced side effects. Moreover, the next theme revealed that participants showed hesitancy to take more than one type of vaccine. Finally, participants were willing to take the vaccine annually, because they believed that the vaccine is better than the disease itself and decreases the aggressive effects of the disease.
CONCLUSIONS: This study found that the majority of participants believed in the safety of the COVID-19 vaccines and emphasized the responsibility of the healthcare providers in increasing awareness among the population about the importance of the vaccines. Enhancing such awareness is essential to improve the acceptance of receiving different types of vaccines.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Journal of pharmaceutical policy and practice - 16(2023), 1 vom: 10. Aug., Seite 100 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Al-Bawab, Rawan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19, Vaccine |
|---|
| Anmerkungen: |
Date Revised 18.11.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1186/s40545-023-00605-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM360631975 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM360631975 | ||
| 003 | DE-627 | ||
| 005 | 20231226083427.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s40545-023-00605-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1202.xml |
| 035 | |a (DE-627)NLM360631975 | ||
| 035 | |a (NLM)37563664 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Al-Bawab, Rawan |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A qualitative assessment of the adverse effects associated with COVID-19 vaccines |b a study from Jordan |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 18.11.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2023. Dr. Zaheer-Ud-Din Babar and Auckland UniServices Ltd. | ||
| 520 | |a OBJECTIVES: The current study aimed to qualitatively explore the side effects reported by participants who received the COVID-19 vaccine among the Jordanian population | ||
| 520 | |a METHODS: Between April 18th and May 12th, 2022, an in-depth interview was conducted with a purposive sample of vaccinated individuals to assess the side effects of the COVID-19 vaccine in this study. Thematic analysis was used to identify themes and sub-themes within the current qualitative data | ||
| 520 | |a RESULTS: A total of 20 participants were interviewed. They had a mean age of 41.3 (SD = 14.3) years. Half of the participants were females (n = 10, 50.0%). The study revealed six main themes: first, most of the respondents believed that COVID-19 vaccines were safe. Second, the vaccines are not equivalent in their safety. The third there showed that participants follow preventive measures to decrease the possibility of experiencing side effects. The fourth theme showed that reporting of side effects by the participants is dependent on the experienced side effects. Moreover, the next theme revealed that participants showed hesitancy to take more than one type of vaccine. Finally, participants were willing to take the vaccine annually, because they believed that the vaccine is better than the disease itself and decreases the aggressive effects of the disease | ||
| 520 | |a CONCLUSIONS: This study found that the majority of participants believed in the safety of the COVID-19 vaccines and emphasized the responsibility of the healthcare providers in increasing awareness among the population about the importance of the vaccines. Enhancing such awareness is essential to improve the acceptance of receiving different types of vaccines | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19, Vaccine | |
| 650 | 4 | |a Immunization | |
| 650 | 4 | |a Jordan | |
| 650 | 4 | |a Side effects | |
| 700 | 1 | |a Abu-Farha, Rana |e verfasserin |4 aut | |
| 700 | 1 | |a El-Dahiyat, Faris |e verfasserin |4 aut | |
| 700 | 1 | |a Nassar, Razan I |e verfasserin |4 aut | |
| 700 | 1 | |a Zawiah, Mohammed |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of pharmaceutical policy and practice |d 2013 |g 16(2023), 1 vom: 10. Aug., Seite 100 |w (DE-627)NLM237669366 |x 2052-3211 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:1 |g day:10 |g month:08 |g pages:100 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s40545-023-00605-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 1 |b 10 |c 08 |h 100 | ||